Neuronal pathology in the hippocampal area of patients with bipolar disorder: A study with proton magnetic resonance spectroscopic imaging

Biological Psychiatry

Volumn 53, Issue 10, 2003, Pages 906-913

  Bertolino, Alessandro ^a   Frye, Mark ^a   Callicott, Joseph H ^a   Mattay, Venkata S ^a   Rakow, Rebecca ^a   Shelton Repella, Jennifer ^a   Post, Robert ^a   Weinberger, Daniel R ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Bipolar disorder; Hippocampus; Magnetic resonance spectroscopy; N acetylaspartate

Indexed keywords

CHOLINE DERIVATIVE; CREATINE; CREATINE PHOSPHATE; N ACETYLASPARTIC ACID;

ADULT; AGED; AMINO ACID BRAIN LEVEL; ARTICLE; BIPOLAR DISORDER; BRAIN DYSFUNCTION; BRAIN FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HIPPOCAMPUS; HUMAN; MALE; NERVE CELL LESION; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SPECTRUM;

EID: 0038735643     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(02)01911-X     Document Type: Article

References (50)

1. Ali S.O., Denicoff K.D., Altshuler L.L., Hauser P., Li X., Conrad A.J., et al. A preliminary study of the relation of neuropsychological performance to neuroanatomic structures in bipolar disorder. Neuropsychiatry Neuropsychol Behav Neurol. 13:2000;20-28.
2. Altshuler L.L., Conrad A., Hauser P., Li X.M., Guze B.H., Denikoff K., et al. Reduction of temporal lobe volume in bipolar disorder A preliminary report of magnetic resonance imaging . Arch Gen Psychiatry. 48:1991;482-483.
3. Benes F.M., Berretta S. GABAergic interneurons Implications for understanding schizophrenia and bipolar disorder . Neuropsychopharmacology. 25:2001;1-27.
4. Bertolino A., Callicott J.H., Elman I., Mattay V.S., Tedeschi G., Frank J.A., et al. Regionally specific neuronal pathology in untreated patients with schizophrenia A proton magnetic resonance spectroscopic imaging study . Biol Psychiatry. 43:1998;641-648.
5. Bertolino A., Callicott J.H., Mattay V.S., Weidenhammer K.M., Rakow R., Egan M.F., Weinberger D.R. The effect of treatment with antipsychotic drugs on brain N- acetylaspartate measures in patients with schizophrenia. Biol Psychiatry. 49:2001;39-46.
6. Bertolino A., Kumra S., Callicott J.H., Mattay V.S., Lestz R.M., Jacobsen L., et al. Common pattern of cortical pathology in childhood-onset and adult-onset schizophrenia as identified by proton magnetic resonance spectroscopic imaging. Am J Psychiatry. 155:1998;1376-1383.
7. Bertolino A., Nawroz S., Mattay V.S., Barnett A.S., Duyn J.H., Moonen C.T., et al. Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging. Am J Psychiatry. 153:1996;1554-1563.
8. Cendes F., Andermann F., Dubeau F., Matthews P.M., Arnold D.L. Normalization of neuronal metabolic dysfunction after surgery for temporal lobe epilepsy. Evidence from proton MR spectroscopic imaging. Neurology. 49:1997;1525-1533.
9. Coffey C.E., Wilkinson W.E., Weiner R.D., Parashos I.A., Djang W.T., Webb M.C., et al. Quantitative cerebral anatomy in depression. A controlled magnetic resonance imaging study. Arch Gen Psychiatry. 50:1993;7-16.
10. Coffman J.A., Bornstein R.A., Olson S.C., Schwarzkopf S.B., Nasrallah H.A. Cognitive impairment and cerebral structure by MRI in bipolar disorder. Biol Psychiatry. 27:1990;1188-1196.
11. Deicken R.F., Eliaz Y., Feiwell R., Schuff N. Increased thalamic N-acetylaspartate in male patients with familial bipolar I disorder. Psychiatry Res. 106:2001;35-45.
12. De Stefano N., Matthews P., Antel J.P., Preul M., Francis G., Arnold D.L. Chemical pathology of acute demyelinating lesions and its correlations with disability. Ann Neurol. 38:1995;901-909.
13. Duvernoy H.M., Cabanis E.A. The Human Brain: Surface, Three-Dimensional Sectional Anatomy, and MRI. 1991;Springer-Verlag, New York.
14. Duyn H., Gillen J., Sobering G., van Zijl P.C., Moonen C.T.W. Multisection proton MR spectroscopic imaging of the brain. Radiology. 188:1993;277-282.
15. Eastwood S.L., Harrison P.J. Hippocampal synaptic pathology in schizophrenia, bipolar disorder and major depression A study of complexin mRNAs . Mol Psychiatry. 5:2000;425-432.
16. First MB, Gibbon M, Spitzer RL, Williams JBW (1996): Guide for the Structured Clinical Interview for DSM-IV Axis I Disorders - Research Version. Washington, DC: American Psychiatric Association.
17. Guidotti A., Auta J., Davis J.M., Di-Giorgi-Gerevini V., Dwivedi Y., Grayson D.R., et al. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder A postmortem brain study . Arch Gen Psychiatry. 57:2000;1061-1069.
18. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 6:1994;278-296.
19. Harvey I., Persaud R., Ron M.A., Baker G., Murray R.M. Volumetric MRI measurements in bipolars compared with schizophrenics and healthy controls. Psychol Med. 24:1994;689-699.
20. Hauser P., Altshuler L.L., Berrettini W., Dauphinais I.D., Gelernter J., Post R.M. Temporal lobe measurement in primary affective disorder by magnetic resonance imaging. J Neuropsychiatry Clin Neurosci. 1:1989;128-134.
21. Heckers S., Stone D., Walsh J., Shick J., Koul P., Benes F.M. Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia. Arch Gen Psychiatry. 59:2002;521-529.
22. Jenkins B.G., Klivenyi P., Kustermann E., Andreassen O.A., Ferrante R.J., Rosen B.R., Beal M.F. Nonlinear decrease over time in N-acetyl aspartate levels in the absence of neuronal loss and increases in glutamine and glucose in transgenic Huntington's disease mice. J Neurochem. 74:2000;2108-2119.
23. Kato T., Inubushi T., Kato N. Magnetic resonance spectroscopy in affective disorders. J Neuropsychiatry Clin Neurosci. 10:1998;133-147.
24. Kemmerer M., Nasrallah H., Sharma S., Olson S., Martin R., Lynn M. Increased hippocampal volume in bipolar disorder. Biol Psychiatry. 35:1994;626.
25. Ketter T.A., George M.S., Kimbrell T.A., Benson B.A., Post R.M. Functional brain imaging, limbic function, and affective disorders. Neuroscientist. 2:1996;55-65.
26. Krishnan K.R., Doraiswamy P.M., Figiel G.S., Husain M.M., Shah S.A., Na C., et al. Hippocampal abnormalities in depression. J Neuropsychiatry Clin Neurosci. 3:1991;387-391.
27. Leverich G.S., Nolen W.A., Rush A.J., Nolen W.A., Denicoff K.D., Altshuler L.L., et al. The Stanley Foundation Bipolar Treatment Outcome Network. I. Longitudinal methodology. J Affect Disord. 67:2001;33-44.
28. Lim K.O., Adalsteinsson E., Spielman D., Sullivan E.V., Rosenbloom M.J., Pfefferbaum A. Proton magnetic resonance spectroscopic imaging of cortical gray and white matter in schizophrenia. Arch Gen Psychiatry. 55:1998;346-352.
29. Mayberg H.S. Frontal lobe dysfunction in secondary depression. J Neuropsychiatry Clin Neurosci. 6:1994;428-442.
30. Mayberg H.S., Liotti M., Brannan S.K., McGinnis S., Mahurin R.K., Jerabek P.A., et al. Reciprocal limbic-cortical function and negative mood Converging PET findings in depression and normal sadness . Am J Psychiatry. 156:1999;675-682.
31. Moffett J.R., Namboodiri M.A. Differential distribution of N-acetylaspartylglutamate and N-acetylaspartate immunoreactivities in rat forebrain. J Neurocytol. 24:1995;409-433.
32. Moore G.J., Bebchuk J.M., Hasanat K., Chen G., Seraji-Bozorgzad N., Wilds I.B., et al. Lithium increases N-acetyl-aspartate in the human brain In vivo evidence in support of bcl-2's neurotrophic effects? Biol Psychiatry. 48:2000;1-8.
33. Ongur D., Drevets W.C., Price J.L. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci U S A. 95:1998;13290-13295.
34. Gorham D.R., Overall J.E. The brief psychiatric rating scale. Psychol Rep. 10:1962;799-812.
35. Rajkowska G. Cell pathology in bipolar disorder. Bipolar Disord. 4:2002;105-116.
36. Renshaw P.F., Lafer B., Babb S.M., Fava M., Stoll A.L., Christensen J.D., et al. Basal ganglia choline levels in depression and response to fluoxetine treatment An in vivo proton magnetic resonance spetroscopy study . Biol Psychiatry. 41:1997;837-843.
37. Richards T.L. Proton MR spectroscopy in multiple sclerosis Value in establishing diagnosis, monitoring progression, and evaluating therapy . AJR Am J Roentgenol. 157:1991;1073-1078.
38. Rubin E., Sackeim H.A., Prohovnik I., Moeller J.R., Schnur D.B., Mukherjee S. Regional cerebral blood flow in mood disorders IV. Comparison of mania and depression . Psychiatry Res. 61:1995;1-10.
39. Sackeim H.A., Prohovnik I., Moeller J.R., Mayeux R., Stern Y., Devanand D.P. Regional cerebral blood flow in mood disorders. I. Comparison of major depressives and normal controls at rest. Arch Gen Psychiatry. 47:1990;60-70.
40. Schlaepfer T.E., Harris G.J., Tien A.Y., Peng L.W., Lee S., Federman E.B., et al. Decreased regional cortical gray matter volume in schizophrenia. Am J Psychiatry. 151:1994;842-848.
41. Sharma R., Venkatasubramanian P.N., Barany M., Davis J.M. Proton magnetic resonance spectroscopy of the brain in schizophrenic and affective patients. Schizophr Res. 8:1992;43-49.
42. Soares J.C., Mann J.J. The functional neuroanatomy of mood disorders. J Psychiat Res. 31:1997;393-432.
43. Stoll A., Renshaw P.F., De Micheli E., Wurtmann R., Pillay S.S., Cohen B. Choline ingestion increases the resonance of choline-containing compounds in human brain An in vivo proton magnetic resonance study . Biol Psychiatry. 37:1995;170-174.
44. Swayze V.W. II, Andreasen N.C., Alliger R.J., Yuh W.T., Ehrhardt J.C. Subcortical and temporal structures in affective disorder and schizophrenia A magnetic resonance imaging study . Biol Psychiatry. 31:1992;221-240.
45. Talairach J., Tournoux P. Coplanar Stereotaxic atlas of the Human Brain. 1998;Thieme Medical Publishers, New York.
46. Urenjak J., Williams S.R., Gadian D.G., Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci. 13:1993;981-989.
47. Vawter M.P., Freed W.J., Kleinman J.E. Neuropathology of bipolar disorder. Biol Psychiatry. 48:2000;486-504.
48. Vion-Dury J., Salvan A.M., Confort-Gouny S., Dhiver C., Cozzone P. Reversal of brain metabolic alterations with zidovudine detected by proton localised magnetic resonance spectroscopy. Lancet. 345:1995;60-61.
49. Winsberg M.E., Sachs N., Tate D.L., Adalsteinsson E., Spielman D., Ketter T.A. Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder. Biol Psychiatry. 47:2000;475-481.
50. Young R.C., Biggs J.T., Ziegler V.E. A rating scale for mania: Reliability, validity and sensitivity. Br J Psychiatry. 133:2000;429-435.